A detailed history of Health Invest Partners Ab transactions in Abb Vie Inc. stock. As of the latest transaction made, Health Invest Partners Ab holds 35,618 shares of ABBV stock, worth $7.18 Million. This represents 3.83% of its overall portfolio holdings.

Number of Shares
35,618
Previous 29,346 21.37%
Holding current value
$7.18 Million
Previous $5.34 Million 14.34%
% of portfolio
3.83%
Previous 3.32%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $970,842 - $1.13 Million
6,272 Added 21.37%
35,618 $6.11 Million
Q1 2024

Apr 25, 2024

BUY
$159.82 - $182.1 $1.3 Million - $1.48 Million
8,150 Added 38.45%
29,346 $5.34 Million
Q4 2023

Jan 30, 2024

BUY
$137.6 - $154.97 $2.8 Million - $3.16 Million
20,385 Added 2513.56%
21,196 $3.28 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $112,169 - $134,520
811 New
811 $131,000
Q1 2022

May 05, 2022

SELL
$131.98 - $163.75 $6.34 Million - $7.86 Million
-48,000 Closed
0 $0
Q4 2021

Jan 18, 2022

BUY
$107.43 - $135.93 $3.55 Million - $4.49 Million
33,000 Added 220.0%
48,000 $6.5 Million
Q3 2021

Nov 08, 2021

SELL
$106.4 - $120.78 $7.45 Million - $8.45 Million
-70,000 Reduced 82.35%
15,000 $1.62 Million
Q2 2021

Aug 10, 2021

BUY
$105.21 - $117.21 $1.68 Million - $1.88 Million
16,000 Added 23.19%
85,000 $9.57 Million
Q1 2021

Apr 30, 2021

SELL
$102.3 - $112.62 $1.84 Million - $2.03 Million
-18,000 Reduced 20.69%
69,000 $7.47 Million
Q4 2020

Feb 05, 2021

BUY
$80.49 - $108.67 $7 Million - $9.45 Million
87,000 New
87,000 $9.32 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $357B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Health Invest Partners Ab Portfolio

Follow Health Invest Partners Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Invest Partners Ab, based on Form 13F filings with the SEC.

News

Stay updated on Health Invest Partners Ab with notifications on news.